Daniel T. Scavilla - 22 May 2026 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Reporting relationship: President, CEO & Member of BOD, Director
Issuer ticker: XRAY
Reported as of: 22 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 May 2026, 18:04:28 UTC
Prior SEC filing: 12 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jessica Nielsen Causey, Attorney-in-Fact for Daniel T. Scavilla

Key filing fact

Daniel T. Scavilla filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 26 May 2026.

Key facts

This page summarizes Daniel T. Scavilla's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 May 2026, 18:04.

Change

Previous filing in this sequence was filed on 12 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001642439 Primary reporting owner

Scavilla Daniel T

Relationship: President, CEO & Member of BOD, Director
Address: C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE
Signature: /s/ Jessica Nielsen Causey, Attorney-in-Fact for Daniel T. Scavilla
Signature date: 26 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XRAY transaction

Common Stock

Tax liability

Transaction value
Shares: -4,095
Change %: -2.5%
Price: $10.21^*
Shares after: 157,754
Date: 22 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.